1714 results for Treatments
Refine Your Search
Improving outcomes with immune therapies for multiple myeloma
The primary focus of research is to better understand mechanisms of resistance to immunotherapies and design treatment approaches to improve outcomes.…
Fanconi Anemia Research Fund
To find effective treatments and a cure for Fanconi anemia (FA) and to provide education and support services to affected families worldwide. Pr…
Have a Nice Day Foundation
To bring sunshine to parents with cancer, by granting extraordinary experiences (Nice*Days) and creating lasting memories for families fighting cancer…
Immune Deficiency Foundation
To improve the diagnosis, treatment and quality of life of persons with primary immunodeficiency diseases through advocacy, education and research. …
Mosunetuzumab with lenalidomide augmentation as first-line therapy for patients with follicular and marginal zone lymphoma
Dr. Olszewski’s trial will examine mosunetuzumab as a first-line treatment for follicular and marginal zone lymphomas—slow-growing types of B-cell lym…
Joe’s House
To centralize the various lodging options and to streamline the reservations process. Website lists thousands of places to stay across the count…
Look Good Feel Better for Teens
This program was created by the Look Good Feel Better Foundation and the Professional Beauty Association to help girls and guys between the ages of 13…
Charlie
At two and a half years old, Charlie was diagnosed with acute lymphoblastic leukemia (ALL).Soon after being diagnosed, she underwent surgery to insert…
Barry
I was diagnosed with non-Hodgkin lymphoma in May of 2003. The diagnosis came after three or four months of tests attempting to diagnose a lump from m…
Development of a clinical program for myeloid cancer prevention
Tmdshe majority of myeloid cancers remain incurable. We previously showed that individuals at risk can be identified years in advance, indicating that…
Developing Novel Immunotherapies for Challenging Lymphomas
This team science program from Washington University will develop new immunotherapy treatments for patients with hard to treat or incurable lymphomas.…
Kristen
I am a mom of four, married for 22 years, and was recently diagnosed with a very rare leukemia/lymphoma. I am a licensed speech-language pathologist, …
Improving CAR-T cell therapy outcomes for patients with for aggressive lymphoma and multiple myeloma
Despite the promise of CAR-T cell immunotherapy for patients with lymphoma and multiple myeloma, a significant proportion of patients fail to respond …
GNAS as a new therapeutic target for MDS
Myelodysplastic syndrome (MDS) is a blood disease with poor prognosis and frequent progression to acute myeloid leukemia (AML). There are currently no…
CLL Patient Databases
Maintains information on a large number of patients with chronic lymphocytic leukemia to contribute to medical research about its diagnosis, prognosis…
Rocco
Our little Roc was diagnosed with leukemia on June 30. We immediately started treatment at Joe DiMaggio Children’s Hospital on July 1 where Rocco was …
Bruce
I was diagnosed with mantle cell lymphoma (MCL) in August 2019 at age 64. It was an accidental find while scanning for a kidney stone. I was late stag…
Mouth and Throat Sores
The lining of your mouth and throat are particularly susceptible to damage from cancer treatment. Chemotherapy and other anticancer drugs can cause th…
Nancy
I was diagnosed with multiple myeloma in 2008. For a year, I was in the “watch and wait” category with no treatment until the disease progressed. In A…
Discovery and therapeutic targeting of novel mechanisms driving Double Hit Lymphomas
Double-hit lymphoma (DHL) is an aggressive form of diffuse large B-cell lymphoma (DLBCL) defined by co-occuring MYC and BCL2 rearrangements. DHL has b…
Improving BTK Inhibitor Therapy in Chronic Lymphocytic Leukemia Through Rational Combination Strategies
Ibrutinib is a targeted oral treatment for CLL that is safe and highly effective, however it must be given indefinitely which leads to chronic side ef…
Defining PIK3R5-related PI3K gamma dependency as a novel therapeutic target in blood cancers including BPDCN
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive blood cancer without adequate treatment. In a genome-wide CRISPR interference sc…
Mantle Cell Lymphoma Video Vignettes for Healthcare Professionals
Developed through a collaboration between The Leukemia & Lymphoma Society & The Association of Cancer Care Centers.This video series provides an overv…
Education Resources
Myeloma Euronet
To provide information on appropriate diagnosis, treatment, care and support for myeloma patients and their families. Advocates for myeloma pati…
CancerCare
To provide free, professional support services to individuals, families, caregivers and the bereaved to help them cope with and manage the emotional a…